A Dose-Ranging Trial to Optimize the Dose of Rifampin in the Treatment of Tuberculosis
- Submitting institution
-
University College London
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 1630
- Type
- D - Journal article
- DOI
-
10.1164/rccm.201407-1264OC
- Title of journal
- AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Article number
- -
- First page
- 1058
- Volume
- 191
- Issue
- 9
- ISSN
- 1073-449X
- Open access status
- Out of scope for open access requirements
- Month of publication
- May
- Year of publication
- 2015
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
17
- Research group(s)
-
-
- Citation count
- 153
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- The author made a substantial contribution to: A (i) the conception and design of the study; A (ii) the organisation of the conduct of the study; A (iii) carrying out the study; A (iv) analysis and interpretation of study data; B (ii) critique the output for important intellectual content.
- Non-English
- No
- English abstract
- -